Veracyte (NASDAQ:VCYT) Now Covered by Analysts at UBS Group
UBS Group initiated coverage on shares of Veracyte (NASDAQ:VCYT – Free Report) in a report published on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $43.00 price objective on the biotechnology company’s stock. Several other research analysts have also commented on VCYT. Morgan Stanley boosted their price objective on shares […]
More Stories
Is Sweet Magnolias Season 6 Renewed? Latest News and Review
Netflix’s romantic drama Sweet Magnolias has finally come to an end. In September 2026, Deadline officially announced that one of...
The Inbetweeners 3: Release Date, Cast, Trailer, and Updates
The Inbetweeners 3 is finally coming back on the popular streaming Network, Netflix. The original four stars of the series,...
7 Essential Components of a Modern Corporate Training Tech Stack
What the seven components need to accomplish Your LMS isn’t obsolete. It may simply need to play one part in...
Climate-ready workplaces in 2026: managing heat, flooding, ice and severe weather
Irish and British workplaces are facing severe weather with increasing frequencies, from heatwares and flash flooding to ice underfoot. Preparing...
7 Best Bespoke Smoke Vents for Large and Complex Roof Openings (2026)
Picture a main contractor in Leeds coordinating a logistics warehouse where the structural grid leaves a 2,800 mm clear zone...
6 College Football Teams Generating the Most Betting Interest in 2026
Three weeks into the 2026 college football season, several familiar contenders are already shaping national conversations. Early results have shifted...